We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Gets DDMAC Letter for Facebook Widget, Brochure
Novartis Gets DDMAC Letter for Facebook Widget, Brochure
August 25, 2011
Novartis received two untitled letters in late July 2010 from the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC), one on Facebook advertising for its leukemia treatment Tasigna and another on a brochure for hypertension drug Exforge.